198 related articles for article (PubMed ID: 24675890)
1. Doxorubicin enhances Snail/LSD1-mediated PTEN suppression in a PARP1-dependent manner.
Lin Y; Kang T; Zhou BP
Cell Cycle; 2014; 13(11):1708-16. PubMed ID: 24675890
[TBL] [Abstract][Full Text] [Related]
2. PARP inhibitor ABT-888 affects response of MDA-MB-231 cells to doxorubicin treatment, targeting Snail expression.
Mariano G; Ricciardi MR; Trisciuoglio D; Zampieri M; Ciccarone F; Guastafierro T; Calabrese R; Valentini E; Tafuri A; Del Bufalo D; Caiafa P; Reale A
Oncotarget; 2015 Jun; 6(17):15008-21. PubMed ID: 25938539
[TBL] [Abstract][Full Text] [Related]
3. Nuclear PTEN interferes with binding of Ku70 at double-strand breaks through post-translational poly(ADP-ribosyl)ation.
Guan J; Zhao Q; Mao W
Biochim Biophys Acta; 2016 Dec; 1863(12):3106-3115. PubMed ID: 27741411
[TBL] [Abstract][Full Text] [Related]
4. Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition.
Lin T; Ponn A; Hu X; Law BK; Lu J
Oncogene; 2010 Sep; 29(35):4896-904. PubMed ID: 20562920
[TBL] [Abstract][Full Text] [Related]
5. PARP1-LSD1 functional interplay controls transcription of SOD2 that protects human pro-inflammatory macrophages from death under an oxidative condition.
Tokarz P; Płoszaj T; Regdon Z; Virág L; Robaszkiewicz A
Free Radic Biol Med; 2019 Feb; 131():218-224. PubMed ID: 30529301
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting interactions of lysine demethylase LSD1 with snail/slug blocks cancer cell invasion.
Ferrari-Amorotti G; Fragliasso V; Esteki R; Prudente Z; Soliera AR; Cattelani S; Manzotti G; Grisendi G; Dominici M; Pieraccioli M; Raschellà G; Chiodoni C; Colombo MP; Calabretta B
Cancer Res; 2013 Jan; 73(1):235-45. PubMed ID: 23054398
[TBL] [Abstract][Full Text] [Related]
7. The malignant brain tumor (MBT) domain protein SFMBT1 is an integral histone reader subunit of the LSD1 demethylase complex for chromatin association and epithelial-to-mesenchymal transition.
Tang M; Shen H; Jin Y; Lin T; Cai Q; Pinard MA; Biswas S; Tran Q; Li G; Shenoy AK; Tongdee E; Lin S; Gu Y; Law BK; Zhou L; Mckenna R; Wu L; Lu J
J Biol Chem; 2013 Sep; 288(38):27680-27691. PubMed ID: 23928305
[TBL] [Abstract][Full Text] [Related]
8. GATA3 cooperates with PARP1 to regulate CCND1 transcription through modulating histone H1 incorporation.
Shan L; Li X; Liu L; Ding X; Wang Q; Zheng Y; Duan Y; Xuan C; Wang Y; Yang F; Shang Y; Shi L
Oncogene; 2014 Jun; 33(24):3205-16. PubMed ID: 23851505
[TBL] [Abstract][Full Text] [Related]
9. Poly(ADP-ribose)-dependent regulation of Snail1 protein stability.
Rodríguez MI; González-Flores A; Dantzer F; Collard J; de Herreros AG; Oliver FJ
Oncogene; 2011 Oct; 30(42):4365-72. PubMed ID: 21577210
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.
Hu K; Wu W; Li Y; Lin L; Chen D; Yan H; Xiao X; Chen H; Chen Z; Zhang Y; Xu S; Guo Y; Koeffler HP; Song E; Yin D
EMBO Rep; 2019 May; 20(5):. PubMed ID: 30940648
[TBL] [Abstract][Full Text] [Related]
11. The histone methyltransferase SMYD2 methylates PARP1 and promotes poly(ADP-ribosyl)ation activity in cancer cells.
Piao L; Kang D; Suzuki T; Masuda A; Dohmae N; Nakamura Y; Hamamoto R
Neoplasia; 2014 Mar; 16(3):257-64, 264.e2. PubMed ID: 24726141
[TBL] [Abstract][Full Text] [Related]
12. PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, Talazoparib.
Ding X; Zhu Z; Lapek J; McMillan EA; Zhang A; Chung CY; Dubbury S; Lapira J; Firdaus S; Kang X; Gao J; Oyer J; Chionis J; Rollins RA; Li L; Niessen S; Bagrodia S; Zhang L; VanArsdale T
Sci Rep; 2022 Jul; 12(1):12501. PubMed ID: 35864202
[TBL] [Abstract][Full Text] [Related]
13. The role of p38 signaling and poly(ADP-ribosyl)ation-induced metabolic collapse in the osteogenic differentiation-coupled cell death pathway.
Robaszkiewicz A; Valkó Z; Kovács K; Hegedűs C; Bakondi E; Bai P; Virág L
Free Radic Biol Med; 2014 Nov; 76():69-79. PubMed ID: 25078118
[TBL] [Abstract][Full Text] [Related]
14. MORC2 regulates DNA damage response through a PARP1-dependent pathway.
Zhang L; Li DQ
Nucleic Acids Res; 2019 Sep; 47(16):8502-8520. PubMed ID: 31616951
[TBL] [Abstract][Full Text] [Related]
15. PARP targeting counteracts gliomagenesis through induction of mitotic catastrophe and aggravation of deficiency in homologous recombination in PTEN-mutant glioma.
Majuelos-Melguizo J; Rodríguez MI; López-Jiménez L; Rodríguez-Vargas JM; Martí Martín-Consuegra JM; Serrano-Sáenz S; Gavard J; de Almodóvar JM; Oliver FJ
Oncotarget; 2015 Mar; 6(7):4790-803. PubMed ID: 25576921
[TBL] [Abstract][Full Text] [Related]
16. Poly(ADP-ribosyl)ation of histone H1 correlates with internucleosomal DNA fragmentation during apoptosis.
Yoon YS; Kim JW; Kang KW; Kim YS; Choi KH; Joe CO
J Biol Chem; 1996 Apr; 271(15):9129-34. PubMed ID: 8621564
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism of poly(ADP-ribosyl)ation by PARP1 and identification of lysine residues as ADP-ribose acceptor sites.
Altmeyer M; Messner S; Hassa PO; Fey M; Hottiger MO
Nucleic Acids Res; 2009 Jun; 37(11):3723-38. PubMed ID: 19372272
[TBL] [Abstract][Full Text] [Related]
18. Poly(ADP-ribose) polymerase 1 is a key regulator of estrogen receptor α-dependent gene transcription.
Zhang F; Wang Y; Wang L; Luo X; Huang K; Wang C; Du M; Liu F; Luo T; Huang D; Huang K
J Biol Chem; 2013 Apr; 288(16):11348-57. PubMed ID: 23493398
[TBL] [Abstract][Full Text] [Related]
19. HMG20A is required for SNAI1-mediated epithelial to mesenchymal transition.
Rivero S; Ceballos-Chávez M; Bhattacharya SS; Reyes JC
Oncogene; 2015 Oct; 34(41):5264-76. PubMed ID: 25639869
[TBL] [Abstract][Full Text] [Related]
20. LSD1 Inhibition Promotes Epithelial Differentiation through Derepression of Fate-Determining Transcription Factors.
Egolf S; Aubert Y; Doepner M; Anderson A; Maldonado-Lopez A; Pacella G; Lee J; Ko EK; Zou J; Lan Y; Simpson CL; Ridky T; Capell BC
Cell Rep; 2019 Aug; 28(8):1981-1992.e7. PubMed ID: 31433976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
